What is LOPJLB’s current signal on MEIP?

LOPJLB’s latest quantitative signal on MEI Pharma, Inc. (MEIP) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is MEIP in?

MEI Pharma, Inc. (MEIP) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does MEI Pharma, Inc. (MEIP) do?

MEI Pharma, Inc. is a late-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for various cancers. Its robust pipeline features several key assets: Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor, is currently in a Phase III clinical trial for relapsed/refractory follicular lymphoma and a Phase Ib multi-arm st…

Where is MEI Pharma, Inc. based / listed?

MEI Pharma, Inc. is based in US, listed on NASDAQ.

MEI Pharma, Inc. (MEIP)

Healthcare · Biotechnology · NASDAQ · US

$2.60+1.56%Close

SELLCRISIS · day 24

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 8
GARP: 1
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-54.5%

REV YoY-

ROE-41.7%

EPS YoY-

ROA-105.2%

GROSS

-4857

NET

-5085

[VALUATION]

P/E TTM-1.53

P/E FWD-

SECTOR PE22.62

INDUSTRY PE17.13

P/B1.93

P/FCF-

EV/EBITDA-0.22

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO11.53

ND/EBITDA-

BETA0.22

NET INCOME (TTM) < 0

MEI Pharma, Inc. (MEIP)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news